FaReWell Depression - Facial Exercise Program to Treat Depression
NCT ID: NCT03983291
Last Updated: 2024-08-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
40 participants
INTERVENTIONAL
2019-06-01
2025-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Feasibility of Resistance Exercise to Treat Major Depression Via Cerebrovascular Mechanisms
NCT05695365
Exercise for Depression
NCT02874833
Trial Investigating the Effect of Different Exercise Forms on Depression
NCT00103415
Implementation of a Multiple Intervention to Promote Healthy Lifestyles in Patients With Depression
NCT06990035
Exploring Clinical Study Experiences of People With Depression
NCT05937932
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Studies have shown that interruption of facial feedback by the injection of botulinum toxin into the corrugator and procerus muscles, which express negative emotions like sadness, anger, and fear, can reduce the symptoms of depression.
In the present study we investigate, if similar effects can be achieved by a relaxing massage of these and other muscles that are associated with the expression of negative emotions and if strengthening exercises of muscles that express positive emotions, the zygomaticus and orbicularis oculi muscles, can contribute to the rehabilitation of positive emotionality in depression. After instruction by a physiotherapist, participants will practice the exercises daily for 15 minutes.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
FaReWell Depression
Physiotherapeutic exercises for the relaxation of facial muscles associated with the expression of negative emotions and for the activation and strengthening of facial muscles associated with the expression of positive emotions 15 minutes daily
FaReWell Depression
Facial massage and force exercise
Resting exercise
Resting 15 minutes daily
FaReWell Depression
Facial massage and force exercise
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
FaReWell Depression
Facial massage and force exercise
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Stable treatment for at least 6 weeks
Exclusion Criteria
* Mental disorders due to psychoactive substance use
* Schizophrenia and other psychotic disorders
* Previous cosmetic procedures (botulinum toxin, fillers, lifting)
* Facial palsy
* Facial skin disorders
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Zentrum für Angst und Depressionsbehandlung Zürich
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Patricia Waldvogel, PhD
Role: PRINCIPAL_INVESTIGATOR
Zentrum für Angst und Depressionsbehandlung Zürich
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Zentrum für Angst- und Depressionsbehandlung
Zurich, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Version 1.1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.